Analytical Data
-
Gene name
EFNA2
- Application
-
Alternative Names
ELF-1; EPLG6; HEK7-L; LERK6; EPH-related receptor tyrosine kinase ligand 6; HEK7 ligand
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O43921
-
Expression Region
Asn45~Ser213
-
Molecular Weight
23kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EFNA2, or Ephrin-A2, is a glycoprotein belonging to the ephrin family that plays a crucial role in various biological processes, including neuronal development, angiogenesis, and cell adhesion. It interacts with Eph receptors, mediating bidirectional signaling that influences cell position and migration during embryogenesis and tissue homeostasis. The significance of EFNA2 is underscored by its involvement in pathological conditions, particularly in cancers where its expression is often dysregulated. Understanding the molecular mechanisms underlying EFNA2's function can provide valuable insights into tumor progression and metastasis. The production of recombinant EFNA2 is essential for studying its properties, including its interaction with Eph receptors and its role in cellular signaling pathways. By generating and purifying recombinant EFNA2, researchers aim to investigate its structural characteristics, binding affinities, and biological activities in vitro. This could facilitate the development of therapeutic strategies targeting EFNA2 and its signaling pathways in diseases where its function is altered. Thus, the study of recombinant EFNA2 not only contributes to a deeper understanding of cell signaling dynamics but also holds potential for advancing cancer treatment approaches.
